These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 379331)

  • 1. Ames test of 1-(X-phenyl)-3,3-dialkyltriazenes. A quantitative structure-activity study.
    Venger BH; Hansch C; Hatheway GJ; Amrein YU
    J Med Chem; 1979 May; 22(5):473-6. PubMed ID: 379331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 2. On the role of correlation analysis in decision making in drug modification. Toxicity quantitative structure-activity relationships of 1-(X-phenyl)-3,3-dialkyltriazenes in mice.
    Hansch C; Hatheway GJ; Quinn FR; Greenberg N
    J Med Chem; 1978 Jun; 21(6):574-7. PubMed ID: 671454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ames test and antitumor activity of 1-(X-phenyl)-3,3-dialkyltriazenes. Quantitative structure-activity studies based upon molecular shape analysis.
    Hopfinger AJ; Potenzone R
    Mol Pharmacol; 1982 Jan; 21(1):187-95. PubMed ID: 7132958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenic activity of the dacarbazine analog p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt in bacterial cells.
    Tamaro M; Dolzani L; Monti-Bragadin C; Sava G
    Pharmacol Res Commun; 1986 May; 18(5):491-501. PubMed ID: 3526359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenicity of substituted (o-phenylenediamine)platinum dichloride in the Ames test. A quantitative structure-activity analysis.
    Hansch C; Venger BH; Panthananickal A
    J Med Chem; 1980 Apr; 23(4):459-61. PubMed ID: 6991694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 1. Quantitative structure-activity relationships vs. L1210 leukemia in mice.
    Hatheway GJ; Hansch C; Kim KH; Milstein SR; Schmidt CL; Smith RN; Quinn FR
    J Med Chem; 1978 Jun; 21(6):563-74. PubMed ID: 671453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenicity of dimethyl heteroaromatic triazenes in the Ames test: the role of hydrophobicity and electronic effects.
    Shusterman AJ; Debnath AK; Hansch C; Horn GW; Fronczek FR; Greene AC; Watkins SF
    Mol Pharmacol; 1989 Dec; 36(6):939-44. PubMed ID: 2601689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenicity of some substituted 1-phenyl-3,3-dimethyltriazenes. I. The salmonella/mammalian microsome assay and repair test.
    Cerná M; Lepsí P; Rössner P; Pohlová H
    Mutat Res; 1987 Mar; 190(3):177-82. PubMed ID: 3547117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat and mouse tissue-mediated mutagenicity of ring-substituted 3,3-dimethyl-1-phenyltriazenes in Salmonella typhimurium.
    Malaveille C; Kolar GF; Bartsch H
    Mutat Res; 1976 Jul; 36(1):1-10. PubMed ID: 7749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International Commission for Protection Against Environmental Mutagens and Carcinogens. The importance of the hydrophobic interaction in the mutagenicity of organic compounds.
    Debnath AK; Shusterman AJ; Lopez de Compadre RL; Hansch C
    Mutat Res; 1994 Feb; 305(1):63-72. PubMed ID: 7508548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of the biotransformation of various antineoplastic agents using the Ames test].
    Oblapenko NG; Prikhod'ko AZ; Fonshteĭn LM; Chernov VA
    Eksp Onkol; 1988; 10(5):52-5. PubMed ID: 3061779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mutagenicity of chemically synthesized metabolites of 16,17-dihydro-15H-cyclopenta[a]phenanthrene and its carcinogenic 11-methyl homologue.
    Papaparaskeva-Petrides C; Ioannides C; Boyd GW; Young RJ; Harvey RG; Coombs MM
    Mutagenesis; 1993 Jul; 8(4):307-10. PubMed ID: 8377648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of a streamlined bacterial mutagenicity assay, the MINISCREEN.
    Brooks TM
    Mutagenesis; 1995 Sep; 10(5):447-8. PubMed ID: 8544759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of rat and guinea pig as sources of the S9 fraction in the Salmonella/mammalian microsome mutagenicity test.
    Baker RS; Bonin AM; Stupans I; Holder GM
    Mutat Res; 1980 Jun; 71(1):43-52. PubMed ID: 6993931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagens, carcinogens, and computers.
    Rosenkranz HS; Klopman G
    Prog Clin Biol Res; 1986; 209A():71-104. PubMed ID: 3529111
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of highly purified cytochrome P-450 isozymes in the activation of 4-aminobiphenyl to mutagenic products in the Ames test.
    Masson HA; Ioannides C; Gorrod JW; Gibson GG
    Carcinogenesis; 1983 Dec; 4(12):1583-6. PubMed ID: 6418403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mutagenicity of dinitrotoluenes in Salmonella typhimurium.
    Couch DB; Allen PF; Abernethy DJ
    Mutat Res; 1981 Dec; 90(4):373-83. PubMed ID: 7038460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Ames-test study with dyes.
    Herbold BA; Arni P; Engelhardt G; Gericke D; Longstaff E
    Mutat Res; 1982 Dec; 97(6):429-35. PubMed ID: 6755242
    [No Abstract]   [Full Text] [Related]  

  • 19. The mutagenicity of aflatoxin Q1 to Salmonella typhimurium TA 100 with or without rat or human liver microsomal preparations.
    Yourtee DM; Kirk-Yourtee CL
    Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):101-13. PubMed ID: 3099349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Salmonella mutagenicity test: evaluation of 29 drug candidates.
    Aaron CS; Mazurek J; Zimmer DM; Swenson DH
    Mutat Res; 1989 Jun; 223(2):171-82. PubMed ID: 2662001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.